Secret NIH Meeting Eyes CRISPR for Fast Pathogen Detection
Published Date: 3/24/2025
Notice
Summary
The National Institute of Allergy and Infectious Diseases is holding a closed meeting on April 21, 2025, to review secret contract proposals about using CRISPR tech to quickly detect certain pathogens. This affects small businesses competing for research funding and keeps sensitive info private. The meeting helps decide who gets money to develop cool new diagnostic tools.
Analyzed Economic Effects
1 provisions identified: 1 benefits, 0 costs, 0 mixed.
Closed SBIR Review for CRISPR Diagnostics
If you are a small business competing for the SBIR Phase II contract (PHS 2023-1) on adapting CRISPR-based in vitro diagnostics for rapid detection of select eukaryotic pathogens, NIH will hold a closed review meeting on April 21, 2025, from 1:00 p.m. to 4:00 p.m. in Rockville, MD (video-assisted). The meeting is closed to the public to protect confidential trade secrets, patentable commercial property, and personal information contained in the contract proposals.
Personalized for You
How does this regulation affect your finances?
Personalize government policy and PRIA will tell you what this federal register document means for your household, plus every other regulation we track. PRIA reads each provision against your financial profile to show you exactly what matters to your wallet.
Key Dates
Department and Agencies
Related Federal Register Documents
2026-20771, Center for Scientific Review; Notice of Closed Meetings
The Center for Scientific Review at the NIH is holding several closed virtual meetings in early November 2026 to review and evaluate grant applications. These meetings protect private info and trade secrets, affecting researchers seeking funding. No direct money changes are announced, but these reviews decide who gets research grants.
2026-20705, Prospective Grant of Exclusive License, Inter-Institutional Agreement-Institution Lead: Antibody Specifically Binding to Severe Fever With Thrombocytopenia Syndrome Virus Antigen and Use Thereof
The National Institute of Allergy and Infectious Diseases plans to give Korea National Institute of Health an exclusive license to develop and sell a special antibody that targets a dangerous virus causing severe fever and low platelets. This deal helps speed up turning the invention into real-world treatments. Comments or license requests must be sent by October 26, 2026.
2026-20424, National Cancer Institute; Notice of Meeting
The President's Cancer Panel is holding a free virtual meeting on October 15, 2026, to talk about how GLP-1 medications can help lower cancer risks linked to obesity. Anyone interested can join online or send in comments beforehand. This meeting is a great chance for patients, doctors, and researchers to learn about new ways to fight cancer and improve health.
2026-20365, Center For Scientific Review; Notice of Closed Meetings
The NIH's Center for Scientific Review is holding several closed virtual meetings on October 29-30, 2026, to review and evaluate grant applications. These meetings protect private info and trade secrets while deciding which research projects get funding. Scientists applying for grants in areas like biochemistry, software engineering, and mental health will be affected, with no direct money changes announced but important decisions coming soon.
2026-20151, Notice of NIH Tribal Consultations and Listening Session
The NIH is inviting Tribal leaders and members to join two important meetings and a listening session during the National Congress of American Indians Annual Convention in October 2026. They’ll talk about new health research projects, renewing support for Tribal health centers, and shaping a new Tribal Data Sovereignty Policy. Tribes can also send their thoughts by November 20, 2026, helping shape future health programs and policies.
2026-19719, Center for Scientific Review; Amended Notice of Meeting
The NIH’s Center for Scientific Review is shortening a key meeting from two days to just one day on October 13, 2026, keeping the same 9 a.m. to 6 p.m. hours. This change affects members of the Surgical Sciences and Bioengineering review group and means less time in the room but no public access. No money changes or delays are expected—just a quicker, tighter meeting!
Previous / Next Documents
Previous: 2025-04943, National Institute of Allergy and Infectious Diseases; Notice of Closed Meeting
The National Institute of Allergy and Infectious Diseases is holding a private meeting on April 17, 2025, to review special grant applications focused on HIV/AIDS research using nonhuman primate models. This closed meeting protects sensitive information like trade secrets and personal details. Researchers applying for these grants should note the review date as it impacts funding decisions.
Next: 2025-04945, National Institute of Allergy and Infectious Diseases; Notice of Closed Meeting
The National Institute of Allergy and Infectious Diseases is holding a closed meeting from April 14-16, 2025, to review secret contract proposals about new tests for Mycoplasma genitalium infection. This meeting affects researchers and companies working on diagnostics and keeps sensitive info private. No public access or funding changes are announced, but important decisions on contracts will happen behind the scenes.